Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-17-067235

VP, Regulatory Affairs sold 16,170 shares at $1.13 ($18,272)

From the SEC's structured data for this filing

Trades in this filing

Yamashita Elizabeth A. · VP, Regulatory Affairs

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2017-12-22 Sale : show line 1 in the form −16,170 $1.13 $18,272 64,648 D
Open-market sales · 16,170 sh · avg $1.13 · $18,272
Loading xslF345X03/doc4.xml…